AZ32
50mg
| ≥99%
CSNpharm
AZ32
250mg
| ≥99%
CSNpharm
CSNpharm
AZ3451
100mg
| ≥99%
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
Azaperone functions as a dopamine antagonist that can bind to D1 and D2 receptors. It has the characteristics of antihistamines and anticholinergics.
More Information
Supplier Page
CSNpharm
Azaperone functions as a dopamine antagonist that can bind to D1 and D2 receptors. It has the characteristics of antihistamines and anticholinergics.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
Azathioprine can inhibit GTP-binding protein Rac1 activation and purine synthesis. Azathioprine is used to treat organ transplantation and autoimmune diseases.
More Information
Supplier Page
CSNpharm
Azathioprine can inhibit GTP-binding protein Rac1 activation and purine synthesis. Azathioprine is used to treat organ transplantation and autoimmune diseases.
More Information
Supplier Page
CSNpharm
Azathioprine can inhibit GTP-binding protein Rac1 activation and purine synthesis. Azathioprine is used to treat organ transplantation and autoimmune diseases.
More Information
Supplier Page
CSNpharm
Azathramycin is an antibiotic used for the treatment of a number of bacterial infections with elimination half-life of 11–14 h.
More Information
Supplier Page
CSNpharm
Azathramycin is an antibiotic used for the treatment of a number of bacterial infections with elimination half-life of 11–14 h.
More Information
Supplier Page
CSNpharm
Azathramycin is an antibiotic used for the treatment of a number of bacterial infections with elimination half-life of 11–14 h.
More Information
Supplier Page
CSNpharm
Azathramycin is an antibiotic used for the treatment of a number of bacterial infections with elimination half-life of 11–14 h.
More Information
Supplier Page
CSNpharm
AZD3264 is an IkB-kinase IKK2 Inhibitor. IKK2 has been identified as one of the pathways to treat inflammatory conditions such as asthma, chronic pulmonary obstructive disorder (COPD) and rheumatoid arthritis.
More Information
Supplier Page
CSNpharm
AZD3264 is an IkB-kinase IKK2 Inhibitor. IKK2 has been identified as one of the pathways to treat inflammatory conditions such as asthma, chronic pulmonary obstructive disorder (COPD) and rheumatoid arthritis.
More Information
Supplier Page
CSNpharm
AZD3264 is an IkB-kinase IKK2 Inhibitor. IKK2 has been identified as one of the pathways to treat inflammatory conditions such as asthma, chronic pulmonary obstructive disorder (COPD) and rheumatoid arthritis.
More Information
Supplier Page
CSNpharm
AZD3264 is an IkB-kinase IKK2 Inhibitor. IKK2 has been identified as one of the pathways to treat inflammatory conditions such as asthma, chronic pulmonary obstructive disorder (COPD) and rheumatoid arthritis.
More Information
Supplier Page
CSNpharm
AZD3264 is an IkB-kinase IKK2 Inhibitor. IKK2 has been identified as one of the pathways to treat inflammatory conditions such as asthma, chronic pulmonary obstructive disorder (COPD) and rheumatoid arthritis.
More Information
Supplier Page
CSNpharm
AZD7545 is a selective inhibitor of PDHK2 (PDH kinase2) with IC50s of 36.8 nM and 6.4 nM for PDHK1 and PDHK2 respectively.
More Information
Supplier Page
CSNpharm
AZD7545 is a selective inhibitor of PDHK2 (PDH kinase2) with IC50s of 36.8 nM and 6.4 nM for PDHK1 and PDHK2 respectively.
More Information
Supplier Page
CSNpharm
AZD7545 is a selective inhibitor of PDHK2 (PDH kinase2) with IC50s of 36.8 nM and 6.4 nM for PDHK1 and PDHK2 respectively.
More Information
Supplier Page
CSNpharm
AZD7545 is a selective inhibitor of PDHK2 (PDH kinase2) with IC50s of 36.8 nM and 6.4 nM for PDHK1 and PDHK2 respectively.
More Information
Supplier Page
CSNpharm
AZD7545 is a selective inhibitor of PDHK2 (PDH kinase2) with IC50s of 36.8 nM and 6.4 nM for PDHK1 and PDHK2 respectively.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm